ORIGINAL RESEARCH
Accepted on 08 Sep 2025
GSTP1 Improves CAR-T Cell Proliferation and Cytotoxicity to Combat Lymphoma
doi 10.3389/fimmu.2025.1665407
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Exploring Unconventional T Cells and CAR-T-Cells in Cancer Immunotherapy
Exploring Unconventional T Cells and CAR-T-Cells in Cancer Immunotherapy
7,851
Total downloads
27k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 24 Jun 2025
Utilizing plasma exchange for severe cytokine release syndrome after CAR-T cell therapy: clinical experience and literature insights
doi 10.3389/fimmu.2025.1597512
- 1,356 views
ORIGINAL RESEARCH
Published on 30 May 2025
Cord blood-derived iNK T cells as a platform for allogeneic CAR T cell therapy
doi 10.3389/fimmu.2025.1621260
- 2,214 views
ORIGINAL RESEARCH
Published on 28 Nov 2024
The effector function of mucosal associated invariant T cells alters with aging and is regulated by RORγt
doi 10.3389/fimmu.2024.1504806
- 1,603 views
ORIGINAL RESEARCH
Published on 15 Nov 2024
Single cell RNA-sequencing of feline peripheral immune cells with V(D)J repertoire and cross species analysis of T lymphocytes
doi 10.3389/fimmu.2024.1438004
- 3,590 views
- 2 citations
ORIGINAL RESEARCH
Published on 09 Sep 2024
Transcriptional re-programming of liver-resident iNKT cells into T-regulatory type-1-like liver iNKT cells involves extensive gene de-methylation
doi 10.3389/fimmu.2024.1454314
- 2,109 views
ORIGINAL RESEARCH
Published on 09 Aug 2024
Distinct characteristics of unique immunoregulatory canine non-conventional TCRαβpos CD4negCD8αneg double-negative T cell subpopulations
doi 10.3389/fimmu.2024.1439213
- 1,556 views
- 1 citation
REVIEW
Published on 31 Jul 2024
Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells
doi 10.3389/fimmu.2024.1432015
- 4,042 views
ORIGINAL RESEARCH
Published on 31 Jul 2024
Porcine γδ T cells express cytotoxic cell-associated markers and display killing activity but are not selectively cytotoxic against PRRSV- or swIAV-infected macrophages
doi 10.3389/fimmu.2024.1434011
- 3,753 views
- 4 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: